Lipella Pharmaceuticals Inc. Disclosure


Lipella Pharmaceuticals Inc. (NASDAQ: LIPO) is a client of PCG Advisory, Inc. Lipella Pharmaceuticals Inc. has an agreement in place to pay PCG a monthly fee of
$15,000, for PCG investor awareness and investor relations advisory services.

Investor awareness and investor relations services and programs are designed to help small-cap companies communicate their investment characteristics. PCG investor awareness and advisory services include multimedia marketing and other awareness services.